AstraZeneca holders approve listing in London, NYC and Stockholm

AstraZeneca (AZN) announced that at the General Meeting of shareholders held earlier today, shareholders approved the resolution to adopt new articles of association of the company, as required to proceed with the harmonization of the company’s equity listing structure. Michel Demare, Chair AstraZeneca said: “Today’s significant vote in favour of the Board’s proposal demonstrates strong shareholder support for AstraZeneca’s harmonised listing structure in London, Stockholm and New York. As the Company continues to expand and invest in our growing markets, our new structure will offer the flexibility to access the broadest available pool of capital, including in the US, enabling more shareholders to participate in AstraZeneca’s exciting future.”